---
title: Julie Louise Gerberding, M.D., MPH
date: 2018-09-13 15:08:18 +0000
role: Co-Chair
short_title: Merck & Co, Inc.
long_title: Executive Vice President and Chief Patient Officer, Merck & Co, Inc.
has_photo: true
short_bio: "**Dr. Julie Gerberding** is Executive Vice President and Chief Patient
  Officer at Merck, where she is responsible for patient engagement, communications,
  policy, philanthropic and other functions. She joined Merck in 2010 as president
  of Merck Vaccines. Dr. Gerberding previously served as Director of the U.S. Centers
  for Disease Control and Prevention (CDC) from 2002 to 2009."
published: false

---
**Dr. Julie Gerberding** is Executive Vice President and Chief Patient Officer at Merck and is responsible for a broad portfolio of patient engagement, communications, policy, philanthropic and other functions. She joined Merck in 2010 as president, Merck Vaccines.  
  
Dr. Gerberding served as Director of the U.S. Centers for Disease Control and Prevention (CDC) from 2002 to 2009. She led the agency through more than 40 emergency responses to public health crises.   
  
Dr. Gerberding has received more than 50 awards and honors, including the United States Department of Health and Human Services Distinguished Service Award for her leadership in responses to anthrax bioterrorism and the September 11, 2001 attacks. She was named to Forbes Magazine's 100 Most Powerful Women in the world from 2005-2008 and to TIME Magazine's 100 Most Influential People in the World in 2004. In 2018, she was named the Healthcare Business Womenâ€™s Association Woman of the Year.  
  
Dr. Gerberding received her undergraduate and M.D. degrees from Case Western Reserve University. She completed her internship and residency in Internal Medicine and fellowship in Clinical Pharmacology and Infectious Diseases at the University of California, San Francisco, where she is currently an Adjunct Associate Professor of Medicine. Dr. Gerberding received a Masters of Public Health at the University of California, Berkeley. She is a member of the National Academy of Medicine and a fellow of the Infectious Diseases Society of America and the American College of Physicians. She is board certified in Internal Medicine and Infectious Diseases.  
  
She serves on the Boards of Cerner Corporation and the MSD Wellcome Trust Hilleman Laboratories, a non-profit that develops new technologies for developing countries.